Emily C Costerison

Title: Emily C Costerison: Innovator in Cytokine Receptor Research

Introduction

Emily C Costerison is a prominent inventor based in San Francisco, CA. She has made significant contributions to the field of biotechnology, particularly in the area of cytokine receptors. Her innovative work has implications for understanding and treating various human diseases.

Latest Patents

Costerison holds a patent for "Polynucleotides encoding cytokine receptor zcytor19." This patent describes novel polypeptides and polynucleotides that encode the zcytor19 receptor, a class II cytokine receptor. The polypeptides can be utilized in methods for detecting ligands that stimulate the proliferation and development of hematopoietic, lymphoid, and myeloid cells both in vitro and in vivo. Additionally, these ligand-binding receptor polypeptides can block ligand activity, providing potential therapeutic applications. The polynucleotides encoding zcytor19 are located on chromosome 1p36.11, which can help identify regions of the genome associated with human disease states. The invention also includes methods for producing the protein and related antibodies.

Career Highlights

Costerison is currently associated with Zymogenetics, Inc., where she continues her research and development efforts. Her work has been instrumental in advancing the understanding of cytokine receptors and their roles in human health.

Collaborations

Costerison has collaborated with notable colleagues, including Scott R Presnell and Theodore E Whitmore. These partnerships have enhanced her research and contributed to the success of her projects.

Conclusion

Emily C Costerison is a trailblazer in the field of cytokine receptor research, with a patent that holds promise for future medical advancements. Her contributions continue to impact the scientific community and pave the way for innovative treatments.